MIOSAN CAF 5 MG + 30 MG COM REV CT BL AL PLAS TRANS X 4

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1011806110016
  • GGREM 501605001111313
  • Código de barras 7896637024822

O que a fonte publica

Detentor do registro
APSEN FARMACEUTICA S/A
Princípios ativos
CLORIDRATO DE CICLOBENZAPRINA;CAFEÍNA
Embalagem
5 MG + 30 MG COM REV CT BL AL PLAS TRANS X 4
Tipo de produto
Novo
Classe terapêutica
M3B - RELAXANTE MUSCULAR DE AÇÃO CENTRAL

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:501605001111313
{
  "name": "MIOSAN CAF 5 MG + 30 MG COM REV CT BL AL PLAS TRANS X 4",
  "holder": "APSEN FARMACEUTICA S/A",
  "stripe": null,
  "barcodes": [
    "7896637024822"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "501605001111313",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "62.462.015/0001-29",
  "priceRegime": "Regulado",
  "productName": "MIOSAN CAF",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "5 MG + 30 MG COM REV CT BL AL PLAS TRANS X 4",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "5.01",
    "icms-12": "5.69",
    "icms-17": "6.04",
    "icms-18": "6.11",
    "icms-19": "6.19",
    "icms-20": "6.26",
    "icms-21": "6.34",
    "icms-22": "6.42",
    "icms-23": "6.51",
    "icms-17.5": "6.07",
    "icms-19.5": "6.22",
    "icms-20.5": "6.30",
    "icms-22.5": "6.46",
    "icms-12-alc": "5.08",
    "icms-17-alc": "5.39",
    "icms-18-alc": "5.46",
    "icms-19-alc": "5.52",
    "icms-20-alc": "5.59",
    "icms-21-alc": "5.66",
    "icms-22-alc": "5.73",
    "icms-23-alc": "5.81",
    "withoutTaxes": "4.47",
    "icms-17.5-alc": "5.42",
    "icms-19.5-alc": "5.56",
    "icms-20.5-alc": "5.63",
    "icms-22.5-alc": "5.77"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "CLORIDRATO DE CICLOBENZAPRINA;CAFEÍNA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "6.72",
    "icms-12": "7.63",
    "icms-17": "8.10",
    "icms-18": "8.20",
    "icms-19": "8.30",
    "icms-20": "8.40",
    "icms-21": "8.50",
    "icms-22": "8.61",
    "icms-23": "8.73",
    "icms-17.5": "8.14",
    "icms-19.5": "8.34",
    "icms-20.5": "8.45",
    "icms-22.5": "8.67",
    "icms-12-alc": "7.02",
    "icms-17-alc": "7.45",
    "icms-18-alc": "7.55",
    "icms-19-alc": "7.63",
    "icms-20-alc": "7.73",
    "icms-21-alc": "7.82",
    "icms-22-alc": "7.92",
    "icms-23-alc": "8.03",
    "withoutTaxes": "6.18",
    "icms-17.5-alc": "7.49",
    "icms-19.5-alc": "7.69",
    "icms-20.5-alc": "7.78",
    "icms-22.5-alc": "7.98"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "CLORIDRATO DE CICLOBENZAPRINA",
    "CAFEÍNA"
  ],
  "therapeuticClass": "M3B - RELAXANTE MUSCULAR DE AÇÃO CENTRAL",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1011806110016",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "M3B",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:501605001111313"